HIGHLIGHTS
- What: The study provides valuable information and raises awareness about the influence of race/ethnicity, mutational status, timing of treatment delivery and efficacy in AM. The study showed that Peruvian patients with AM have poor clinico-pathological features, and limited response to IO.
- Who: Denisse Castro and collaborators from the Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Jesús María, Lima, PeruCentro de Investigación de Medicina de Precisión, Universidad de San Martin de Porres, La Molina, Lima, Peru have published the research work: Clinicopathological features, response patterns . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.